Compound for detecting cancer
The invention aims at providing a compound which can be used as a color indicator. The compound reaches a maximum light absorption value at 450nm; hydroxyproline in serum of a cancer patient is determined by using coloration of the compound, so that the aims of quickness and accuracy can be achieved...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
06.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention aims at providing a compound which can be used as a color indicator. The compound reaches a maximum light absorption value at 450nm; hydroxyproline in serum of a cancer patient is determined by using coloration of the compound, so that the aims of quickness and accuracy can be achieved and further rapid and quantitative analysis of a marker in the serum of the cancer patient is realized. Compared with enzyme-linked immunosorbent assay and a genetic testing method low in sensitivity and complex in operation, a detection method based on research of the compound provided by the invention is simple and convenient in operation, and is rapid in result showing; according to clinical trial data, the compound has higher sensitivity and specificity for detection effects of gastric cancer, lung cancer, cervical cancer, esophagus cancer, breast cancer, colorectal cancer, ovarian cancer, endometrial cancer, laryngocarcinoma, thyroid cancer, liver cancer and the like; the positive rate can reach 90.3 percent |
---|---|
Bibliography: | Application Number: CN201510970621 |